Severe Complications Triplicate the Costs of Major Surgical Procedures

This study has been completed.
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00855387
First received: March 3, 2009
Last updated: November 25, 2009
Last verified: November 2009
  Purpose

The purpose of this study is to prospectively assess the impact of surgical quality on the overall cost of major surgical procedures using the incidence and severity of complications as surrogate markers of quality.


Condition Intervention
Major Surgical Procedures
Other: No additional intervention than the intended major surgery in pancreas, liver, colorectal, gastric bypass and small bowel

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Surgical Complications Dramatically Influence Overall Cost of Major Surgical Procedures

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Clinical outcome (complications) In-hospital Costs [ Time Frame: inhospital; peri-operative ] [ Designated as safety issue: Yes ]

Enrollment: 1235
Study Start Date: March 2009
Study Completion Date: November 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Costs
Patients collected consecutively for undergoing major surgical procedures(liver, bile duct, pancreas, small bowel, colo-rectal, gastric bypass resections).
Other: No additional intervention than the intended major surgery in pancreas, liver, colorectal, gastric bypass and small bowel
No additional intervention than the intended major surgery (liver, bile duct, pancreas, colorectal, gastric bypass and small bowel resections) comparing with costs

Detailed Description:

To prospectively assess the impact of surgical quality on the overall cost of major surgical procedures using the incidence and severity of complications as surrogate markers of quality

  Eligibility

Ages Eligible for Study:   12 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

A cohort study with 1235 patients including consecutive patients undergoing major surgery (liver, bile duct, pancreas, colorectal, gastric bypass and small bowel resections) in a single tertiary care center

Criteria

Inclusion Criteria:

  • Undergoing major surgery (liver, bile duct, pancreas, colorectal, gastric bypass and small bowel resections)

Exclusion Criteria:

  • Missing data of in-hospital costs
  • Mortality
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00855387

Locations
Switzerland
University Hospital of Zurich, Department of Visceral and Transplantation Surgery
Zurich, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: René Vonlanthen, Dr. med. Department of Visceral and Transplantation Surgery
  More Information

No publications provided by University of Zurich

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: R. Vonlanthen/Dr. med., University Hospital of Zurich
ClinicalTrials.gov Identifier: NCT00855387     History of Changes
Other Study ID Numbers: StV 5-2009
Study First Received: March 3, 2009
Last Updated: November 25, 2009
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Zurich:
Clinical outcome (complications), in-hospital costs
The influence and impact of postoperative complications on in-hospital costs

Additional relevant MeSH terms:
Pancreatin
Pancrelipase
Gastrointestinal Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on July 23, 2014